BIOMAT Database Logo BIOMAT Database Logo

Stability of somatostatin in total parenteral nutrition. 1990

J B Montoro, and R Galard, and R Catalan, and J Martinez, and P Salvador, and P Sabin
Hospital Pharmacy Service, Hospital General Vall d'Hebron, Barcelona, Spain.

The stability of somatostatin, added to a total parenteral nutrition formula, in glass containers and in plastic ethylene vinyl acetate containers was investigated. The somatostatin concentration decreased immediately from 3 micrograms/ml to 0.3-0.6 micrograms/ml after addition to the emulsion. In spite of this rapid decrease, somatostatin concentrations remained stable with values of 0.4-0.7 micrograms/ml during the follow-up period (24 h). These findings could be explained assuming adsorption to the surface of the container.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D010289 Parenteral Nutrition, Total The delivery of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously, or by some other non-alimentary route. The basic components of TPN solutions are protein hydrolysates or free amino acid mixtures, monosaccharides, and electrolytes. Components are selected for their ability to reverse catabolism, promote anabolism, and build structural proteins. Hyperalimentation, Parenteral,Intravenous Hyperalimentation,Nutrition, Total Parenteral,Parenteral Hyperalimentation,Total Parenteral Nutrition,Hyperalimentation, Intravenous
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004349 Drug Packaging Containers, packaging, and packaging materials for drugs and BIOLOGICAL PRODUCTS. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. (From Code of Federal Regulations, 21 CFR 1 Section 210, 1993) DRUG LABELING is also available. Drug Containers and Closures,Packaging, Drug,Drug Containers,Container, Drug,Containers, Drug,Drug Container,Drug Packagings,Packagings, Drug
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D004655 Emulsions Colloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES. Emulsion
D005898 Glass Hard, amorphous, brittle, inorganic, usually transparent, polymerous silicate of basic oxides, usually potassium or sodium. It is used in the form of hard sheets, vessels, tubing, fibers, ceramics, beads, etc.
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone
D014753 Vinyl Compounds Compounds containing the vinyl (-C Compounds, Vinyl

Related Publications

J B Montoro, and R Galard, and R Catalan, and J Martinez, and P Salvador, and P Sabin
[Somatostatin stability in parenteral nutrition units].
January 1991, Nutricion hospitalaria,
J B Montoro, and R Galard, and R Catalan, and J Martinez, and P Salvador, and P Sabin
Aminophylline stability in total parenteral nutrition admixtures.
January 1995, Acta poloniae pharmaceutica,
J B Montoro, and R Galard, and R Catalan, and J Martinez, and P Salvador, and P Sabin
Selenium stability in total parenteral nutrition solutions.
January 1990, JPEN. Journal of parenteral and enteral nutrition,
J B Montoro, and R Galard, and R Catalan, and J Martinez, and P Salvador, and P Sabin
[Stability of Insulin in Total Parenteral Nutrition Solutions].
January 2020, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
J B Montoro, and R Galard, and R Catalan, and J Martinez, and P Salvador, and P Sabin
Chylous ascites: treated with total parenteral nutrition and somatostatin.
September 2004, World journal of gastroenterology,
J B Montoro, and R Galard, and R Catalan, and J Martinez, and P Salvador, and P Sabin
Storage of mixtures for total parenteral nutrition--long-term stability of a total parenteral nutrition mixture.
September 1983, Journal of clinical and hospital pharmacy,
J B Montoro, and R Galard, and R Catalan, and J Martinez, and P Salvador, and P Sabin
Somatostatin in persistent gastrointestinal fistula treated by total parenteral nutrition.
August 1982, Lancet (London, England),
J B Montoro, and R Galard, and R Catalan, and J Martinez, and P Salvador, and P Sabin
Treatment of pancreatic fistulas with somatostatin and total parenteral nutrition.
September 1989, Scandinavian journal of gastroenterology,
J B Montoro, and R Galard, and R Catalan, and J Martinez, and P Salvador, and P Sabin
Long-term stability of cimetidine in total parenteral nutrition.
February 1996, Journal of clinical pharmacy and therapeutics,
J B Montoro, and R Galard, and R Catalan, and J Martinez, and P Salvador, and P Sabin
[Stability of Six Drugs in Total Parenteral Nutrition Solution].
January 2021, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Copied contents to your clipboard!